How much did DNA Chip Research achieve in EBIT for the current year?
In the current year, DNA Chip Research has achieved an EBIT of -258.22 M JPY.
DNA Chip Research EBIT 2024
DNA Chip Research EBIT
-258.22 M JPY
Ticker
2397.T
ISIN
JP3548590003
In 2024, DNA Chip Research's EBIT was -258.22 M JPY, a -28.84% increase from the -362.89 M JPY EBIT recorded in the previous year.
The DNA Chip Research EBIT history
| YEAR | EBIT (undefined JPY) |
|---|---|
| 2024 | -258.22 |
| 2023 | -362.89 |
| 2022 | -166.61 |
| 2021 | -172.2 |
| 2020 | -123.32 |
| 2019 | -99.53 |
| 2018 | -125.03 |
| 2017 | -152.56 |
| 2016 | -178.84 |
| 2015 | -99.43 |
| 2014 | -44.8 |
| 2013 | -89.9 |
| 2012 | -165.3 |
| 2011 | -153.7 |
| 2010 | -205.7 |
| 2009 | -288.4 |
| 2008 | -340.4 |
| 2007 | -335.3 |
| 2006 | -264.3 |
| 2005 | 87.7 |
DNA Chip Research Revenue, EBIT, Net Income JP3548590003 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into DNA Chip Research, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by DNA Chip Research from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects DNA Chip Research’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of DNA Chip Research. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into DNA Chip Research’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing DNA Chip Research’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on DNA Chip Research’s growth potential.
DNA Chip Research Revenue, EBIT and net profit per share
| Date | DNA Chip Research Revenue | DNA Chip Research EBIT | DNA Chip Research Net Income |
|---|---|---|---|
| 2024 | 490.46 M undefined | -258.22 M undefined | -248.29 M undefined |
| 2023 | 327.54 M undefined | -362.89 M undefined | -362.34 M undefined |
| 2022 | 427.94 M undefined | -166.61 M undefined | -134.05 M undefined |
| 2021 | 324.5 M undefined | -172.2 M undefined | -172.47 M undefined |
| 2020 | 361.71 M undefined | -123.32 M undefined | -128.09 M undefined |
| 2019 | 360.81 M undefined | -99.53 M undefined | -104.88 M undefined |
| 2018 | 362.84 M undefined | -125.03 M undefined | -127.58 M undefined |
| 2017 | 324.65 M undefined | -152.56 M undefined | -211.91 M undefined |
| 2016 | 284.16 M undefined | -178.84 M undefined | -203.07 M undefined |
| 2015 | 357.32 M undefined | -99.43 M undefined | -135.92 M undefined |
| 2014 | 349.1 M undefined | -44.8 M undefined | -45.8 M undefined |
| 2013 | 371.9 M undefined | -89.9 M undefined | -80.8 M undefined |
| 2012 | 401.1 M undefined | -165.3 M undefined | -165.6 M undefined |
| 2011 | 593.6 M undefined | -153.7 M undefined | -155.2 M undefined |
| 2010 | 726.7 M undefined | -205.7 M undefined | -204.1 M undefined |
| 2009 | 873 M undefined | -288.4 M undefined | -340.2 M undefined |
| 2008 | 879.4 M undefined | -340.4 M undefined | -345.6 M undefined |
| 2007 | 787.1 M undefined | -335.3 M undefined | -410.8 M undefined |
| 2006 | 759.9 M undefined | -264.3 M undefined | -272.4 M undefined |
| 2005 | 1.15 B undefined | 87.7 M undefined | 54.8 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 1.15 B JPY | 87.7 M JPY | 54.8 M JPY |
| 2006 | 759.9 M JPY | -264.3 M JPY | -272.4 M JPY |
| 2007 | 787.1 M JPY | -335.3 M JPY | -410.8 M JPY |
| 2008 | 879.4 M JPY | -340.4 M JPY | -345.6 M JPY |
| 2009 | 873 M JPY | -288.4 M JPY | -340.2 M JPY |
| 2010 | 726.7 M JPY | -205.7 M JPY | -204.1 M JPY |
| 2011 | 593.6 M JPY | -153.7 M JPY | -155.2 M JPY |
| 2012 | 401.1 M JPY | -165.3 M JPY | -165.6 M JPY |
| 2013 | 371.9 M JPY | -89.9 M JPY | -80.8 M JPY |
| 2014 | 349.1 M JPY | -44.8 M JPY | -45.8 M JPY |
| 2015 | 357.32 M JPY | -99.43 M JPY | -135.92 M JPY |
| 2016 | 284.16 M JPY | -178.84 M JPY | -203.07 M JPY |
| 2017 | 324.65 M JPY | -152.56 M JPY | -211.91 M JPY |
| 2018 | 362.84 M JPY | -125.03 M JPY | -127.58 M JPY |
| 2019 | 360.81 M JPY | -99.53 M JPY | -104.88 M JPY |
| 2020 | 361.71 M JPY | -123.32 M JPY | -128.09 M JPY |
| 2021 | 324.5 M JPY | -172.2 M JPY | -172.47 M JPY |
| 2022 | 427.94 M JPY | -166.61 M JPY | -134.05 M JPY |
| 2023 | 327.54 M JPY | -362.89 M JPY | -362.34 M JPY |
| 2024 | 490.46 M JPY | -258.22 M JPY | -248.29 M JPY |
DNA Chip Research stock margins JP3548590003 ·
The DNA Chip Research margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DNA Chip Research. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DNA Chip Research.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the DNA Chip Research's sales revenue. A higher gross margin percentage indicates that the DNA Chip Research retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the DNA Chip Research's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the DNA Chip Research's total revenue generated. When comparing the revenue margin year over year, investors can gauge the DNA Chip Research's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the DNA Chip Research. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the DNA Chip Research's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
DNA Chip Research Margin History
| DNA Chip Research Gross margin | DNA Chip Research Profit margin | DNA Chip Research EBIT margin | DNA Chip Research Profit margin |
|---|---|---|---|
| 2024 | 13.53 % | -52.65 % | -50.62 % |
| 2023 | -10.86 % | -110.79 % | -110.63 % |
| 2022 | 20.85 % | -38.93 % | -31.32 % |
| 2021 | 20.4 % | -53.06 % | -53.15 % |
| 2020 | 24.79 % | -34.09 % | -35.41 % |
| 2019 | 27.68 % | -27.59 % | -29.07 % |
| 2018 | 32.27 % | -34.46 % | -35.16 % |
| 2017 | 18.75 % | -46.99 % | -65.27 % |
| 2016 | -1.17 % | -62.94 % | -71.46 % |
| 2015 | 13.16 % | -27.83 % | -38.04 % |
| 2014 | 28.07 % | -12.83 % | -13.12 % |
| 2013 | 16.21 % | -24.17 % | -21.73 % |
| 2012 | 16.63 % | -41.21 % | -41.29 % |
| 2011 | 20.65 % | -25.89 % | -26.15 % |
| 2010 | 3.48 % | -28.31 % | -28.09 % |
| 2009 | -2.18 % | -33.04 % | -38.97 % |
| 2008 | -7.91 % | -38.71 % | -39.3 % |
| 2007 | -9.71 % | -42.6 % | -52.19 % |
| 2006 | -4.57 % | -34.78 % | -35.85 % |
| 2005 | 30.02 % | 7.66 % | 4.78 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 30.02 % | 7.66 % | 4.78 % |
| 2006 | -4.57 % | -34.78 % | -35.85 % |
| 2007 | -9.71 % | -42.6 % | -52.19 % |
| 2008 | -7.91 % | -38.71 % | -39.3 % |
| 2009 | -2.18 % | -33.04 % | -38.97 % |
| 2010 | 3.48 % | -28.31 % | -28.09 % |
| 2011 | 20.65 % | -25.89 % | -26.15 % |
| 2012 | 16.63 % | -41.21 % | -41.29 % |
| 2013 | 16.21 % | -24.17 % | -21.73 % |
| 2014 | 28.07 % | -12.83 % | -13.12 % |
| 2015 | 13.16 % | -27.83 % | -38.04 % |
| 2016 | -1.17 % | -62.94 % | -71.46 % |
| 2017 | 18.75 % | -46.99 % | -65.27 % |
| 2018 | 32.27 % | -34.46 % | -35.16 % |
| 2019 | 27.68 % | -27.59 % | -29.07 % |
| 2020 | 24.79 % | -34.09 % | -35.41 % |
| 2021 | 20.4 % | -53.06 % | -53.15 % |
| 2022 | 20.85 % | -38.93 % | -31.32 % |
| 2023 | -10.86 % | -110.79 % | -110.63 % |
| 2024 | 13.53 % | -52.65 % | -50.62 % |
DNA Chip Research Aktienanalyse
What does DNA Chip Research do?
DNA Chip Research ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing DNA Chip Research's EBIT
DNA Chip Research's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of DNA Chip Research's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
DNA Chip Research's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in DNA Chip Research’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about DNA Chip Research stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company DNA Chip Research.
How has the EBIT of DNA Chip Research developed in recent years?
The EBIT of DNA Chip Research has increased by -28.845% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company DNA Chip Research?
The EBIT of DNA Chip Research is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does DNA Chip Research pay?
Over the past 12 months, DNA Chip Research paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DNA Chip Research is expected to pay a dividend of 0 JPY.
What is the dividend yield of DNA Chip Research?
The current dividend yield of DNA Chip Research is .
When does DNA Chip Research pay dividends?
DNA Chip Research pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of DNA Chip Research?
DNA Chip Research paid dividends every year for the past 0 years.
What is the dividend of DNA Chip Research?
For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.
In which sector is DNA Chip Research located?
DNA Chip Research is assigned to the 'Health' sector.
Wann musste ich die Aktien von DNA Chip Research kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of DNA Chip Research from 11/18/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.
When did DNA Chip Research pay the last dividend?
The last dividend was paid out on 11/18/2024.
What was the dividend of DNA Chip Research in the year 2023?
In the year 2023, DNA Chip Research distributed 0 JPY as dividends.
In which currency does DNA Chip Research pay out the dividend?
The dividends of DNA Chip Research are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von DNA Chip Research
Our stock analysis for DNA Chip Research Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DNA Chip Research Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- DNA Chip Research Revenue
- DNA Chip Research Net Income
- DNA Chip Research P/E
- DNA Chip Research P/S
- DNA Chip Research EBIT
- DNA Chip Research Dividend
- DNA Chip Research Stocks
- DNA Chip Research Market capitalization
- DNA Chip Research Debt
- DNA Chip Research Liabilities
- DNA Chip Research Equity
- DNA Chip Research AAQS
- DNA Chip Research Employees
- DNA Chip Research ROE
- DNA Chip Research ROA
- DNA Chip Research ROCE